Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
Cellular & Molecular Immunology
|
May 17, 2020
Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies
Chunyan Yi, Xiaoyu Sun, Jing Ye, et al.
Cell Research
|
April 2, 2020
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
Shuai Xia, Meiqin Liu, Chao Wang, et al.
Nature Communications
|
August 10, 2021
Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylactics
Shaojuan Zhao, Huajun Zhang, Xinglou Yang, et al.
Emerging Microbes & Infections
|
March 26, 2024
Establishment of a human organoid-based evaluation system for assessing interspecies infection risk of animal-borne coronaviruses
Qianchun Gong, Rendi Jiang, Lina Ji, et al.
Brain Research
|
October 6, 2006
A glial cell line-derived neurotrophic factor (GDNF):tetanus toxin fragment C protein conjugate improves delivery of GDNF to spinal cord motor neurons in mice
Kristin E Larsen, Susanna C Benn, Ilknur Ay, et al.
Cell Discovery
|
April 21, 2022
Novel sarbecovirus bispecific neutralizing antibodies with exceptional breadth and potency against currently circulating SARS-CoV-2 variants and sarbecoviruses
Yingdan Wang, Meiqin Liu, Yaping Shen, et al.
Cell Reports
|
December 15, 2021
IFP35 as a promising biomarker and therapeutic target for the syndromes induced by SARS-CoV-2 or influenza virus
Yang Yu, Na Xu, Qi Cheng, et al.
Nature
|
April 10, 2020
Structure of M<sup>pro</sup> from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin, Xiaoyu Du, Yechun Xu, et al.
Nature Nanotechnology
|
June 17, 2026
Precision-engineered STING agonist nanoparticles enable coordinated mucosal-systemic immunity for durable pan-β-coronavirus protection
Zezhong Liu, Jie Zhou, Ruiyu Gao, et al.
Cell
|
February 21, 2023
A bat MERS-like coronavirus circulates in pangolins and utilizes human DPP4 and host proteases for cell entry
Jing Chen, Xinglou Yang, Haorui Si, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
Cellular & Molecular Immunology
|
May 17, 2020
Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies
Chunyan Yi, Xiaoyu Sun, Jing Ye, et al.
Cell Research
|
April 2, 2020
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
Shuai Xia, Meiqin Liu, Chao Wang, et al.
Nature Communications
|
August 10, 2021
Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylactics
Shaojuan Zhao, Huajun Zhang, Xinglou Yang, et al.
Emerging Microbes & Infections
|
March 26, 2024
Establishment of a human organoid-based evaluation system for assessing interspecies infection risk of animal-borne coronaviruses
Qianchun Gong, Rendi Jiang, Lina Ji, et al.
Brain Research
|
October 6, 2006
A glial cell line-derived neurotrophic factor (GDNF):tetanus toxin fragment C protein conjugate improves delivery of GDNF to spinal cord motor neurons in mice
Kristin E Larsen, Susanna C Benn, Ilknur Ay, et al.
Cell Discovery
|
April 21, 2022
Novel sarbecovirus bispecific neutralizing antibodies with exceptional breadth and potency against currently circulating SARS-CoV-2 variants and sarbecoviruses
Yingdan Wang, Meiqin Liu, Yaping Shen, et al.
Cell Reports
|
December 15, 2021
IFP35 as a promising biomarker and therapeutic target for the syndromes induced by SARS-CoV-2 or influenza virus
Yang Yu, Na Xu, Qi Cheng, et al.
Nature
|
April 10, 2020
Structure of M<sup>pro</sup> from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin, Xiaoyu Du, Yechun Xu, et al.
Nature Nanotechnology
|
June 17, 2026
Precision-engineered STING agonist nanoparticles enable coordinated mucosal-systemic immunity for durable pan-β-coronavirus protection
Zezhong Liu, Jie Zhou, Ruiyu Gao, et al.
Cell
|
February 21, 2023
A bat MERS-like coronavirus circulates in pangolins and utilizes human DPP4 and host proteases for cell entry
Jing Chen, Xinglou Yang, Haorui Si, et al.
Page
of 6